NewzA new review of evidence published on Tuesday, September 15, 2026, indicates that the risk of women being diagnosed with and treated for harmless tumors due to breast cancer screening is significantly lower than previously estimated. According to the study reported by HealthDay News, the rate of overdiagnosis is markedly reduced.
The findings provide new insights into the outcomes of routine breast cancer screening programs. By demonstrating a lower incidence of overdiagnosis, the research helps refine the understanding of screening risks versus benefits for women undergoing preventive evaluations.
In-depth summary · AI, neutral